Arkolith/Insider Trading/TMBR/Form 4

TardiMed Sciences LLC

10% OwnerTimber Pharmaceuticals, Inc. (TMBR) · full profile →Form 4 · filed Aug 26, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$276K
Net Open-Market Flow
-$276K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 26, 2021Sell(S)100K$0.92$92K4.1M
Aug 25, 2021Sell(S)100K$0.91$91K4.2M
Aug 24, 2021Sell(S)100K$0.93$93K4.3M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-21-109895) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML